Insider Trading activities at Recursion Pharmaceuticals, Inc. (RXRX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Recursion Pharmaceuticals, Inc. (RXRX) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Recursion Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1601830.

Total stock buying since 2021: $55,945,223.
Total stock sales since 2021: $57,960,010.
Total stock option exercises since 2021: $7,522,154.


 1   2 
12 insiders reported insider trading activities at Recursion Pharmaceuticals, Inc. (RXRX):
Insider trading activities of Secora Michael
Insider trading activities of Doyle Ramona
Insider trading activities of Borgeson Blake
Insider trading activities of Lux Venture Partners Iv, Llc
Insider trading activities of Virani Shafique
Insider trading activities of Gibson Christopher
Insider trading activities of Mamoura Diversified Global Holding Pjsc
Insider trading activities of Li Dean Y
Insider trading activities of Khan Najat
Insider trading activities of Burrell Terry-ann
Insider trading activities of Larson Tina Marriott
Insider trading activities of Dar Zavain

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Recursion Pharmaceuticals, Inc. (RXRX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 1,013,348 $5,649,321 0 $0
2024 0 $0 1,602,491 $13,922,171 884,924 $2,106,116
2023 530,551 $4,145,237 1,747,121 $15,898,927 1,156,160 $2,786,490
2022 0 $0 2,255,836 $20,469,503 1,143,248 $2,558,793
2021 2,877,777 $51,799,986 100,717 $2,020,088 28,646 $70,755

Table 2. Monthly summary of insider trading at Recursion Pharmaceuticals, Inc. (RXRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 754,774 $3,950,136 0 $0
2025-03 0 $0 178,574 $1,095,986 0 $0
2025-02 0 $0 40,000 $315,999 0 $0
2025-01 0 $0 40,000 $287,200 0 $0
2024-12 0 $0 40,000 $285,600 0 $0
2024-11 0 $0 81,447 $618,755 78,750 $174,824
2024-10 0 $0 110,341 $697,184 84,750 $181,184
2024-09 0 $0 98,894 $622,882 84,750 $181,184
2024-08 0 $0 108,894 $738,433 109,750 $243,184
2024-07 0 $0 158,894 $1,195,435 84,750 $181,184
2024-06 0 $0 158,894 $1,398,734 84,750 $181,184
2024-05 0 $0 134,501 $1,144,197 3,000 $3,180
2024-04 0 $0 215,465 $1,830,558 78,000 $169,680
2024-03 0 $0 224,427 $2,453,462 122,924 $452,052
2024-02 0 $0 137,773 $1,439,121 114,250 $252,480
2024-01 0 $0 132,961 $1,497,810 39,250 $85,980
2023-12 0 $0 187,471 $1,559,642 132,250 $292,440
2023-11 0 $0 153,509 $934,423 127,250 $287,140
2023-10 0 $0 157,449 $1,079,567 127,250 $287,140
2023-09 0 $0 147,535 $1,277,826 127,250 $287,140
2023-08 0 $0 162,670 $1,787,021 135,924 $486,712
2023-07 0 $0 359,422 $4,695,214 214,250 $474,480
2023-06 0 $0 176,671 $1,627,607 109,250 $247,180
2023-05 0 $0 78,843 $431,381 34,250 $80,680

Table 3. Detailed insider trading at Recursion Pharmaceuticals, Inc. (RXRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-26 Gibson Christopher (Chief Executive Officer) Sale 100,000 4.84 484,000
2025-08-18 Khan Najat (Chief R&D Commercial Officer) Sale 36,599 5.52 202,172
2025-08-11 Gibson Christopher (Chief Executive Officer) Sale 618,175 5.28 3,263,964
2025-03-27 Gibson Christopher (Chief Executive Officer) Sale 138,574 6.04 836,986
2025-03-06 Gibson Christopher (Chief Executive Officer) Sale 20,000 6.37 127,400
2025-03-05 Gibson Christopher (Chief Executive Officer) Sale 20,000 6.58 131,600
2025-02-06 Gibson Christopher (Chief Executive Officer) Sale 20,000 8.12 162,399
2025-02-05 Gibson Christopher (Chief Executive Officer) Sale 20,000 7.68 153,600
2025-01-10 Gibson Christopher (Chief Executive Officer) Sale 20,000 7.05 141,000
2025-01-08 Gibson Christopher (Chief Executive Officer) Sale 20,000 7.31 146,200
2024-12-05 Gibson Christopher (Chief Executive Officer) Sale 20,000 7.12 142,400
2024-12-04 Gibson Christopher (Chief Executive Officer) Sale 20,000 7.16 143,200
2024-11-14 Gibson Christopher (Chief Executive Officer) Sale 20,000 7.35 147,000
2024-11-13 Gibson Christopher (Chief Executive Officer) Sale 20,000 7.74 154,800
2024-11-13 Secora Michael (Chief Financial Officer) Sale 15,000 7.66 114,870
2024-11-13 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-11-12 Borgeson Blake (Director) Sale 11,447 7.64 87,455
2024-11-12 Secora Michael (Chief Financial Officer) Sale 15,000 7.64 114,630
2024-11-12 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-10-29 Borgeson Blake (Director) Sale 11,447 6.72 76,923
2024-10-24 Marriott Tina (President and COO) Sale 6,000 6.31 37,854
2024-10-24 Marriott Tina (President and COO) Option Ex 6,000 1.06 6,360
2024-10-15 Borgeson Blake (Director) Sale 11,447 6.67 76,328
2024-10-09 Secora Michael (Chief Financial Officer) Sale 15,000 6.36 95,370
2024-10-09 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-10-08 Secora Michael (Chief Financial Officer) Sale 15,000 6.32 94,755
2024-10-08 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-10-03 Gibson Christopher (Chief Executive Officer) Sale 20,000 6.08 121,600
2024-10-02 Gibson Christopher (Chief Executive Officer) Sale 20,000 6.16 123,200
2024-10-01 Borgeson Blake (Director) Sale 11,447 6.22 71,154
2024-09-26 Marriott Tina (President and COO) Sale 6,000 7.00 42,006
2024-09-26 Marriott Tina (President and COO) Option Ex 6,000 1.06 6,360
2024-09-17 Borgeson Blake (Director) Sale 11,447 6.84 78,331
2024-09-11 Secora Michael (Chief Financial Officer) Sale 15,000 6.32 94,725
2024-09-11 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-09-10 Secora Michael (Chief Financial Officer) Sale 15,000 6.17 92,505
2024-09-10 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-09-05 Gibson Christopher (Chief Executive Officer) Sale 20,000 6.14 122,800
2024-09-04 Gibson Christopher (Chief Executive Officer) Sale 20,000 6.04 120,800
2024-09-03 Borgeson Blake (Director) Sale 11,447 6.26 71,715
2024-08-30 Gibson Christopher (Chief Executive Officer) Option Ex 5,000 2.48 12,400
2024-08-29 Marriott Tina (President and COO) Sale 6,000 7.56 45,378
2024-08-29 Marriott Tina (President and COO) Option Ex 6,000 1.06 6,360
2024-08-29 Gibson Christopher (Chief Executive Officer) Option Ex 5,000 2.48 12,400
2024-08-28 Gibson Christopher (Chief Executive Officer) Option Ex 5,000 2.48 12,400
2024-08-26 Gibson Christopher (Chief Executive Officer) Option Ex 5,000 2.48 12,400
2024-08-23 Gibson Christopher (Chief Executive Officer) Option Ex 5,000 2.48 12,400
2024-08-20 Borgeson Blake (Director) Sale 11,447 7.12 81,536
2024-08-14 Secora Michael (Chief Financial Officer) Sale 15,000 6.35 95,250
2024-08-14 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-08-13 Secora Michael (Chief Financial Officer) Sale 15,000 6.35 95,190
2024-08-13 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-08-08 Gibson Christopher (Chief Executive Officer) Sale 20,000 6.50 130,000
2024-08-07 Gibson Christopher (Chief Executive Officer) Sale 30,000 7.10 213,000
2024-08-06 Borgeson Blake (Director) Sale 11,447 6.82 78,079
2024-07-25 Marriott Tina (President and COO) Sale 6,000 8.13 48,810
2024-07-25 Marriott Tina (President and COO) Option Ex 6,000 1.06 6,360
2024-07-23 Borgeson Blake (Director) Sale 11,447 8.48 97,036
2024-07-11 Gibson Christopher (Chief Executive Officer) Sale 50,000 7.47 373,500
2024-07-10 Gibson Christopher (Chief Executive Officer) Sale 50,000 7.48 374,000
2024-07-10 Secora Michael (Chief Financial Officer) Sale 15,000 7.24 108,570
2024-07-10 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-07-09 Borgeson Blake (Director) Sale 11,447 7.32 83,734
2024-07-09 Secora Michael (Chief Financial Officer) Sale 15,000 7.32 109,785
2024-07-09 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-06-27 Marriott Tina (President and COO) Sale 6,000 7.21 43,290
2024-06-27 Marriott Tina (President and COO) Option Ex 6,000 1.06 6,360
2024-06-25 Borgeson Blake (Director) Sale 11,447 9.51 108,803
2024-06-14 Secora Michael (Chief Financial Officer) Sale 15,000 9.27 139,080
2024-06-14 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-06-13 Secora Michael (Chief Financial Officer) Sale 15,000 9.32 139,800
2024-06-13 Secora Michael (Chief Financial Officer) Option Ex 39,375 2.22 87,412
2024-06-11 Borgeson Blake (Director) Sale 11,447 8.45 96,761
2024-06-06 Gibson Christopher (Chief Executive Officer) Sale 50,000 9.00 450,000
2024-06-05 Gibson Christopher (Chief Executive Officer) Sale 50,000 8.42 421,000
2024-05-30 Marriott Tina (President and COO) Sale 3,000 8.78 26,325
2024-05-30 Marriott Tina (President and COO) Option Ex 3,000 1.06 3,180
2024-05-28 Borgeson Blake (Director) Sale 11,447 9.17 104,946
2024-05-14 Borgeson Blake (Director) Sale 20,054 10.12 202,926
2024-05-02 Gibson Christopher (Chief Executive Officer) Sale 50,000 8.47 423,500
2024-05-01 Gibson Christopher (Chief Executive Officer) Sale 50,000 7.73 386,500
2024-04-30 Borgeson Blake (Director) Sale 11,447 7.95 90,969
2024-04-25 Marriott Tina (President and COO) Sale 3,000 7.67 23,022
2024-04-25 Marriott Tina (President and COO) Option Ex 3,000 1.06 3,180
2024-04-17 Secora Michael (Chief Financial Officer) Sale 23,124 7.58 175,349
2024-04-17 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2024-04-16 Borgeson Blake (Director) Sale 11,447 7.66 87,729
2024-04-16 Secora Michael (Chief Financial Officer) Sale 25,000 7.67 191,650
2024-04-16 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2024-04-04 Gibson Christopher (Chief Executive Officer) Sale 65,000 9.02 586,300
2024-04-03 Gibson Christopher (Chief Executive Officer) Sale 65,000 8.84 574,600
2024-04-02 Borgeson Blake (Director) Sale 11,447 8.82 100,939
2024-03-28 Gibson Christopher (Chief Executive Officer) Sale 65,000 10.10 656,500
2024-03-21 Marriott Tina (President and COO) Sale 8,000 11.02 88,144
2024-03-21 Marriott Tina (President and COO) Option Ex 8,000 1.06 8,480
2024-03-19 Borgeson Blake (Director) Sale 20,054 10.79 216,422
2024-03-13 Secora Michael (Chief Financial Officer) Sale 25,000 11.03 275,825
2024-03-13 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2024-03-12 Secora Michael (Chief Financial Officer) Sale 25,000 10.46 261,375
2024-03-12 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2024-03-06 Gibson Christopher (Chief Executive Officer) Sale 61,319 11.63 713,385
2024-03-06 Gibson Christopher (Chief Executive Officer) Option Ex 39,924 6.94 277,072
2024-03-05 Borgeson Blake (Director) Sale 20,054 12.06 241,811
2024-02-22 Marriott Tina (President and COO) Sale 8,000 14.89 119,160
2024-02-22 Marriott Tina (President and COO) Option Ex 8,000 1.06 8,480
2024-02-20 Borgeson Blake (Director) Sale 20,054 12.68 254,224
2024-02-14 Secora Michael (Chief Financial Officer) Sale 25,000 10.71 267,725
2024-02-14 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2024-02-13 Secora Michael (Chief Financial Officer) Sale 25,000 9.86 246,550
2024-02-13 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2024-02-07 Gibson Christopher (Chief Executive Officer) Sale 48,272 9.22 444,971
2024-02-07 Gibson Christopher (Chief Executive Officer) Option Ex 31,250 2.48 77,500
2024-02-06 Borgeson Blake (Director) Sale 11,447 9.30 106,491
2024-01-25 Larson Tina Marriott (President and COO) Sale 8,000 10.35 82,760
2024-01-25 Larson Tina Marriott (President and COO) Option Ex 8,000 1.06 8,480
2024-01-23 Borgeson Blake (Director) Sale 20,054 10.58 212,091
2024-01-09 Borgeson Blake (Director) Sale 20,054 13.51 270,969
2024-01-09 Li Dean Y (Director) Sale 29,000 13.84 401,331
2024-01-03 Gibson Christopher (Chief Executive Officer) Sale 55,853 9.50 530,659
2024-01-03 Gibson Christopher (Chief Executive Officer) Option Ex 31,250 2.48 77,500
2023-12-28 Larson Tina Marriott (President and COO) Sale 8,000 10.58 84,656
2023-12-28 Larson Tina Marriott (President and COO) Option Ex 8,000 1.06 8,480
2023-12-26 Borgeson Blake (Director) Sale 20,054 10.63 213,153
2023-12-15 Virani Shafique (Chief Business Officer) Sale 18,000 9.60 172,800
2023-12-15 Virani Shafique (Chief Business Officer) Option Ex 18,000 2.22 39,960
2023-12-14 Dar Zavain (Director) Sale 20,141 9.00 181,269
2023-12-13 Secora Michael (Chief Financial Officer) Sale 25,000 7.59 189,775
2023-12-13 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2023-12-12 Borgeson Blake (Director) Sale 11,447 7.40 84,696
2023-12-12 Secora Michael (Chief Financial Officer) Sale 25,000 7.39 184,875
2023-12-12 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2023-12-06 Gibson Christopher (Chief Executive Officer) Sale 59,829 7.50 448,418
2023-12-06 Gibson Christopher (Chief Executive Officer) Option Ex 31,250 2.48 77,500
2023-11-28 Borgeson Blake (Director) Sale 11,447 6.72 76,923
2023-11-16 Larson Tina Marriott (President and COO) Sale 3,000 6.76 20,280
2023-11-16 Larson Tina Marriott (President and COO) Option Ex 3,000 1.06 3,180
2023-11-15 Virani Shafique (Chief Business Officer) Sale 18,000 6.51 117,180
2023-11-15 Virani Shafique (Chief Business Officer) Option Ex 18,000 2.22 39,960
2023-11-15 Secora Michael (Chief Financial Officer) Sale 25,000 7.43 185,850
2023-11-15 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2023-11-14 Borgeson Blake (Director) Sale 8,885 6.32 56,153
2023-11-14 Secora Michael (Chief Financial Officer) Sale 25,000 6.32 157,950
2023-11-14 Secora Michael (Chief Financial Officer) Option Ex 37,500 2.22 83,250
2023-11-01 Gibson Christopher (Chief Executive Officer) Sale 62,177 5.15 320,087
2023-11-01 Gibson Christopher (Chief Executive Officer) Option Ex 31,250 2.48 77,500
2023-10-31 Borgeson Blake (Director) Sale 8,885 5.28 46,868
2023-10-26 Larson Tina Marriott (President and COO) Sale 3,000 5.63 16,884
2023-10-26 Larson Tina Marriott (President and COO) Option Ex 3,000 1.06 3,180
2023-10-17 Borgeson Blake (Director) Sale 8,885 6.58 58,481
2023-10-16 Virani Shafique (Chief Business Officer) Sale 18,000 6.30 113,400
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of RXRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Recursion Pharmaceuticals, Inc. (symbol RXRX, CIK number 1601830) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.